Literature DB >> 19139722

Synergistic effect of interleukin-6 and endoplasmic reticulum stress inducers on the high level of ABCG2 expression in plasma cells.

Naoto Nakamichi1, Eiichi Morii, Jun-ichiro Ikeda, Ying Qiu, Suhana Mamato, Tian Tian, Shirou Fukuhara, Katsuyuki Aozasa.   

Abstract

ABCG2 is a transporter preferentially expressed in a primitive subpopulation of cells and recently reported as a surviving factor for trophoblasts. To date, manner of ABCG2 expression in lymphoid tissues is not known. Immunohistochemically, strong ABCG2 expression was found in a small proportion of plasma cells mainly located in the interfollicular space of lymphoid tissues. The number of ABCG2-high plasma cells increased in interleukin-6- (IL-6) rich lesions, such as Castleman's disease of plasma cell type. Plasma cells are subjected to endoplasmic reticulum (ER) stress when excess proteins are synthesized, and IL-6 stimulates protein synthesis. Therefore, the effect of IL-6 and ER stress on ABCG2 expression in plasma cells was examined. The expression level of ABCG2 increased by treatment with either IL-6 or ER stress inducers, and further increased with both. The promoter analysis revealed that the effect of IL-6 and ER stress inducers was mediated through the site overlapping XBP-1 and HIF-1 binding sequences. Knocked-down of ABCG2 by siRNA or ABCG2 inhibitor reduced plasma cell viability under ER stress. These suggest that ABCG2 is a surviving factor for plasma cells. To our knowledge, this is the first study reporting the effect of ER stress on ABCG2 expression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19139722     DOI: 10.1038/labinvest.2008.157

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  6 in total

Review 1.  Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance.

Authors:  Karthika Natarajan; Yi Xie; Maria R Baer; Douglas D Ross
Journal:  Biochem Pharmacol       Date:  2012-01-11       Impact factor: 5.858

2.  Human ABCG2: structure, function, and its role in multidrug resistance.

Authors:  Wei Mo; Jian-Ting Zhang
Journal:  Int J Biochem Mol Biol       Date:  2011-03-30

3.  ABCG2 is upregulated in Alzheimer's brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood-brain barrier for Abeta(1-40) peptides.

Authors:  Huaqi Xiong; Debbie Callaghan; Aimee Jones; Jianying Bai; Ingrid Rasquinha; Catherine Smith; Ke Pei; Douglas Walker; Lih-Fen Lue; Danica Stanimirovic; Wandong Zhang
Journal:  J Neurosci       Date:  2009-04-29       Impact factor: 6.167

4.  The involvement of SMILE/TMTC3 in endoplasmic reticulum stress response.

Authors:  Maud Racapé; Jean-Paul Duong Van Huyen; Richard Danger; Magali Giral; Françoise Bleicher; Yohann Foucher; Annaïck Pallier; Paul Pilet; Petra Tafelmeyer; Joanna Ashton-Chess; Emilie Dugast; Ségolène Pettré; Béatrice Charreau; Jean-Paul Soulillou; Sophie Brouard
Journal:  PLoS One       Date:  2011-05-16       Impact factor: 3.240

5.  Association between DNA methylation in the miR-328 5'-flanking region and inter-individual differences in miR-328 and BCRP expression in human placenta.

Authors:  Jumpei Saito; Takeshi Hirota; Shinji Furuta; Daisuke Kobayashi; Hiroshi Takane; Ichiro Ieiri
Journal:  PLoS One       Date:  2013-08-21       Impact factor: 3.240

6.  Activation of LXRɑ/β by cholesterol in malignant ascites promotes chemoresistance in ovarian cancer.

Authors:  Soochi Kim; Maria Lee; Danny N Dhanasekaran; Yong Sang Song
Journal:  BMC Cancer       Date:  2018-12-10       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.